$834.40
− 9.07− 1.08%
Alpaca · SIPUpdated 19:4215 Minutes Delayed
Balance-sheet ratios aren't available for this company.
It is an automated pre-screen based on the line of business and AAOIFI's widely used financial thresholds; a final judgement rests with your own school of thought and the certification boards that audit the filings.
The interest-income test (5% of revenue) needs a revenue breakdown our free data source doesn't provide, so that criterion isn't screened.
$834.40
Alpaca · SIPUpdated 19:4215 Minutes Delayed
Regeneron Pharmaceuticals is a biotech known for the eye drug Eylea plus allergy and oncology therapies.
CacheUpdated 09:13May Be Out Of Date
Couldn't load data
Average close over the last 50, 100 and 200 trading days. The percentage next to it is how far the current price sits from that average.
No data
This data isn't available right now.
No data
No data